IAM Advisory’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.91M Buy
33,075
+916
+3% +$52.6K 0.37% 47
2026
Q1
$1.95M Buy
32,159
+1,396
+5% +$81.4K 0.44% 37
2025
Q4
$1.66M Buy
+30,763
New +$1.48M 0.37% 43
2023
Q3
Sell
-20,063
Closed -$1.28M 96
2023
Q2
$1.28M Buy
20,063
+1,370
+7% +$91.9K 0.44% 39
2023
Q1
$1.3M Buy
18,693
+2,067
+12% +$146K 0.45% 37
2022
Q4
$1.2M Buy
16,626
+814
+5% +$61.4K 0.44% 34
2022
Q3
$1.12M Buy
15,812
+1,427
+10% +$104K 0.47% 34
2022
Q2
$1.11M Buy
14,385
+556
+4% +$42.3K 0.46% 34
2022
Q1
$1.01M Buy
13,829
+584
+4% +$39.2K 0.41% 39
2021
Q4
$862K Buy
13,245
+1,632
+14% +$95.7K 0.34% 46
2021
Q3
$667K Buy
+11,613
New +$765K 0.28% 53
2021
Q2
Sell
-10,504
Closed -$667K 54
2021
Q1
$667K Buy
10,504
+327
+3% +$20.3K 0.29% 49
2020
Q4
$631K Buy
+10,177
New +$626K 0.32% 47

Other funds holding BMY